Pathophysiology of Metabolic and Emerging Diseases
About the Group
Perform research activities applied to the prevention, diagnosis and treatment of diseases that affect the human population. Generate interdisciplinary solutions to health problems through an approach of Translational Medicine in Metabolic Diseases, bringing together disciplines, resources, knowledge and techniques from various areas for the development of robust and effective solutions through a direct and collaborative dialogue between basic research, technological innovation and clinical practice.
Research lines
- Study of the body's biochemical processes associated with metabolic diseases and their complications.
- Study of the processes of inflammation and oxidative damage associated with chronic degenerative diseases, particularly in metabolic diseases and their complications.
- Development of solutions to the main health problems associated with chronic degenerative diseases, through the creation of innovative processes, devices and drugs, aimed at the prevention, diagnosis and treatment of metabolic diseases.
- Clinical validation of innovative proposals for processes, devices and drugs, considering good clinical practices and national and international regulatory aspects.
Leader
José Guillermo Domínguez Cherit - guillermodc@tec.mx
Core reserchers
Alexandro José Martagón Rosado
Adjunct researchers
Blanca Margarita Bazán Perkins
Carlos Alberto Aguilar Salinas
Diana Gómez Martin
Iván Pérez Díaz
Joaquin Alejandro Zuñiga Ramos
José Alfredo Santibáñez Salgado
José Carlos Crispín Acuña
Josefina María Alberú Gómez
Top 5 of publications 2015-2019
- Achievement of low-density lipoprotein cholesterol goals in 18 countries outside Western Europe: The International ChoLesterol management Practice Study (ICLPS)
Authors: Danchin, N., Almahmeed, W., Al-Rasadi, K., Azuri, J., Berrah, A., Cuneo, C., Karpov, Y., Kaul, U., Kay¿kç¿o¿lu, M., Mitchenko, O., Ruiz, A., Aguilar Salinas, C., Santos, R., Mercier, F., & Blom, D.
- Influenza A (H1N1pdm09)-Related Critical Illness and Mortality in Mexico and Canada, 2014
Authors: Dominguez-Cherit, G., De La Torre, A., Rishu, A., Pinto, R., Ñamendys-Silva, S., Camacho-Ortiz, A., Silva-Medina, M., Hernández-Cárdenas, C., Martínez-Franco, M., Quesada-Sánchez, A., López-Gallegos, G., Mosqueda-Gómez, J., Rivera-Martinez, N., Campos-Calderón, F., Rivero-Sigarroa, E., Hernández-Gilsoul, T., Espinosa-Pérez, L., Macías, A., Lue-Martínez, D., Buelna-Cano, C., Ramírez-García Luna, A., Cruz-Ruiz, N., Poblano-Morales, M., Molinar-Ramos, F., Hernandez-Torre, M., León-Gutiérrez, M., Rosaldo-Abundis, O., Baltazar-Torres, J., Stelfox, H., Light, B., Jouvet, P., Reynolds, S., Hall, R., Shindo, N., Daneman, N., & Fowler, R.
- Exposure to diethylhexyl phthalate (DEHP) and monoethylhexyl phthalate (MEHP) promotes the loss of alveolar epithelial phenotype of A549 cells
Authors: Rafael-Vázquez, L., García-Trejo, S., Aztatzi-Aguilar, O., Bazán-Perkins, B., & Quintanilla-Vega, B.
- Sucralose decreases insulin sensitivity in healthy subjects: A randomized controlled trial
Authors: Romo-Romo, A., Aguilar-Salinas, C., Brito-Córdova, G., Gómez-Díaz, R., & Almeda-Valdes, P.
- The panorama of familial hypercholesterolemia in Latin America: A systematic review
Authors: Mehta, R., Zubirán, R., Martagón, A., Vazquez-Cárdenas, A., Segura-Kato, Y., Tusié-Luna, M., & Aguilar-Salinas, C.
